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The chemotactic peptide, fMet-Leu-Phe (fMLP), induced proto-oncogene c-fos mRNA in purified human 
peripheral granulocytes. The induction was transient, and was inhibited by pertussis toxin or by an inhibitor 
of protein kinase C. These results suggest hat activation of a guanine nucleotide-binding protein and of 
protein kinase C is involved in c-fos induction in granulocytes. 
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1. INTRODUCTION 
Transcription of the proto-oncogene c-fos is 
known to be activated transiently by various 
growth factors and tumor promoters [1-12], and 
has been suggested to be involved in the control of 
cell growth. Transcription of c-fos is also induced 
during cellular differentiation [10,11] and by 
cAMP [13,14]. Most inducers of c-fos reported so 
far are all related to growth factors or mitogens. 
Activation of protein kinase C plays a key role as 
a second messenger for the signal of growth factors 
[15], and as we and others previously reported 
[10,16], c-fos induction depends on the activation 
of protein kinase C. 
It was thus of interest o investigate whether the 
activators of protein kinase C induce c-fos gene in 
the absence of cell growth or differentiation. For 
this purpose, we used freshly isolated human 
peripheral granulocytes which are terminally dif- 
ferentiated and will not divide further in vitro. The 
chemotactic peptide, fMet-Leu-Phe (fMLP), is 
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supposed to activate protein kinase C through the 
activation of cytoplasmic guanine nucleotide- 
binding protein and phospholipase C [17]. Here, 
we examined the effect of fMLP on c-fos gene ex- 
pression in human peripheral granulocytes. 
2. MATERIALS AND METHODS 
Peripheral granulocytes were isolated from nor- 
mal human volunteers by the use of Ficoll-Conray. 
Fresh whole blood was collected in heparin- 
containing syringes. 1 vol. phosphate-buffered 
saline and 0.5 vol. of 4.5o70 dextran (in saline) were 
added, and the mixture was allowed to stand at 
room temperature for 30 min. The upper layer 
above the red blood cell layer was collected and 
spun at 800 rpm for 10 min. The pellet was 
suspended in Hanks' solution and layered on 
Ficoll-Conray solution (d = 1.077). After cen- 
trifugation at 1500 rpm for 30 min, the lower layer 
was collected, and contaminated red blood cells 
were eliminated by addition of 1 vol. distilled 
water. After 30 s, the osmolarity was adjusted by 
adding 10% NaCI. Granulocytes were collected by 
centrifugation at 800 rpm for 10 min, washed with 
Hanks' solution twice and suspended in the same 
solution. 
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0 15 30 60 120n~ Cells were preincubated in a CO2 incubator 
(37°C, 5°70 CO2/95% air) for 2 h. fMLP and in- 
hibitors were added, and cells were incubated fur- 
ther in a CO2 incubator for the indicated times. 
Total RNA was extracted by the guanidinium- 
hot phenol method, and run on a formaldehyde- 
containing agarose gel [18]. After transfer to 
nitrocellulose filters, RNA was hybridized with v- 
fos or ~-actin probes as in [16]. 
3. RESULTS AND DISCUSSION 
The purity of isolated granulocytes was nearly 
95o70 as judged by microscopic observation of 
specimens stained using the May-Griinwald 
method. The observation described below is, 
therefore, most likely manifested in granulocytes, 
not by contaminated lymphocytes or macro- 
phages. 
Isolated granulocytes were incubated with 
50 nM fMLP for 0-120 min or with various doses 
of fMLP for 30 min, and total RNA was ex- 
tracted. Constant amounts of RNA were run on an 
agarose gel containing formaldehyde, transferred 
to membranes and hybridized with 32p-v-fos 
probe. The increase in c-fos mRNA level evoked 
by fMLP was found to be dose- and time- 
dependent (figs 1,2), and was observed at levels as 
low as 2 nM fMLP. The induction was very rapid 
and was maximum within 15 min after addition of 
fMLP. The level of accumulated c-fos mRNA 
declined thereafter, and essentially no c-fos mRNA 
was detected 120 min after the addition of fMLP. 
Kreipe et al. reported that the c-fos mRNA level 
was high in purified human granulocytes [24]. We 
noted that the endogenous level of c-fos mRNA 
differed significantly among different preparations 
of granulocytes, even when the cells were prepared 
from the same donor. However, the level de- 
creased to become undetectable within 120 min of 
preincubation, fMLP being added after the prein- 
cubation in all the experiments. 
The chemotactic peptide, fMLP, is supposed to 
bind to a specific receptor, and to transduce its 
signal via guanine-binding proteins which may 
then interact with phospholipase in membranes 
[19-21]. Such activation may subsequently induce 
phosphatidylinositol turnover, resulting in the ac- 
tivation of protein kinase C [15]. To investigate the 
involvement of such processes in activation of the 
Fig.l. Time course of c-fos induction. Isolated 
granulocytes were incubated in the presence of 50 nM 
fMLP for the indicated times. Total RNA was extracted, 
and 15/~g were run on an agarose gel containing 
formaldehyde. After transfer to filters, filters were 
hybridized with 32p-labeled v-fos or fl-actin probe as 
described in the text. After washing, filters were exposed 
to X-ray films in the presence of an intensifying screen 
for 2 days, and developed. 
c-fos gene, the effects of several inhibitors on the 
putative processes of induction were examined. 
Pertussis toxin is known to inhibit fMLP- 
induced responses of granulocytes by inactivation 
of guanine-binding protein [17]. Fig.3 shows the 
effect of pertussis toxin on the accumulation of c- 
fos mRNA induced by fMLP. Cells were 
pretreated with 0.2 or 1/zg/ml of pertussis toxin 
and fMLP was added. RNA was extracted after 
30 min and analyzed as described above. The 
results clearly indicate that the induction of c-fos 
was inhibited by pertussis toxin. 
We then examined the effect of inhibitors of 
protein kinase on the induction. The isoquinoline 
derivative, 1-(5-isoquinolinesulfonyl)-2-methyl- 
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Fig.2. Induction of c-fos. Ceils were incubated with 
0-250 nM fMLP for 30 min. RNA was extracted and 
hybridized with v-fos probe. 
piperazine (H7), is known to inhibit protein kinase 
C specifically, whereas N-(2-aminoethyl)-5-isoqui- 
nolinesulfonamide (H9) inhibits cyclic nucleotide- 
dependent protein kinases [22]. As shown in fig.4, 
H7 inhibited c-fos induction almost completely, 
whereas H9 showed only a marginal effect. The 
calmodulin antagonist, N-(6-aminohexyl)-5-chloro- 
1-naphthalenesulfonamide (W7) also inhibited in- 
duction. These results indicate that activation of 
protein kinase C is necessary for the induction of 
c-fos by fMLP. 
The proto-oncogene c-fos is suggested to be in- 
volved in growth regulation and differentiation 
[1-11]. Peripheral granulocytes are, however, ter- 
minally differentiated and they neither grow nor 
differentiate further. The present results have 
shown that the c-fos proto-oncogene is induced in 
granulocytes possibly through the signal transduc- 
tion system involved in the usual response of cells 
to chemotactic peptide, suggesting some 
physiological functions of c-fos induction in 
granulocytes. 
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Fig.3. Induction of c-fos induction by pertussis toxin. 
Cells were preincubated with 0.2 (lane 3) or 1/zg/ml 
(lanes 4,5) pertussis toxin for 2 h, and 50 nM fMLP was 
added (lanes 2-4). After incubation for 30 min, RNA 
was extracted and probed with v-fos. 
Fig.4. Inhibition of c-fos induction by inhibitors of 
protein kinase C. H7 (lane 3), H9 (lane 4) or W7 (lane 
5) was placed in the medium at 50/~M and fMLP 
(50 nM, lanes 2-5) was added. RNA was extracted after 
30 min incubation and probed with v-fos. 
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We recently described evidence that superoxide 
is produced in cultured cells stimulated with 
mitogens [23]. The signals which induce c-fos ac- 
tivation seem to give rise to superoxide production 
at the same time. Production of superoxide is 
regarded as a kind of stress for cells, and it may be 
possible that c-fos expression is required under 
such conditions of cellular stress. 
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